Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04795232
Other study ID # Recovery-COD Training-UTH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date June 30, 2023

Study information

Verified date October 2023
Source University of Thessaly
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims at investigating the recovery kinetics of skeletal muscle damage, neuromuscular fatigue and performance following a single change of direction (COD) training session in competitive soccer players. The impact of COD degrees will be also examined by comparing a 45o vs. 90o COD training session. Ten male soccer players will perform a COD45 [A single training session including 2x(10x ~27.6m) sprints with two 45o COD in each sprint], a COD90 [A single training session including 2x(10x ~21.2m) sprints with two 90o COD in each sprint] and a Control trial (No intervention included, only daily measurements) in randomized, repeated measures, crossover design. Assessments related to skeletal muscle damage, neuromuscular fatigue and performance will be performed prior to training session and daily for three consecutive days post-training, in each trial.


Description:

Ten male soccer players will be included in this study. Participants will be initially informed about the aim of study as well as the associated risks and benefits and subsequently will provide their signed consent form. At baseline, they will undergo assessment of their anthropometrics (i.e. body mass and body height), body composition (by DXA), physical conditioning status [maximal oxygen consumption (VO2max), Yo-Yo Intermittent Endurance test level 2 and Yo-Yo Intermittent Recovery test level 2] and daily dietary intake. Thereafter, they will participate in two experimental trials and one control trial in a randomized, crossover, repeated measures design: i) COD45: Participants in this trial will perform a COD training session consisted of 2 sets of 10 x ~27.6m sprints with two 45o COD in each sprint and a resting period of 16 sec and 2:20 min between sprints and sets, respectively, ii) COD90: Participants in this trial will perform a COD training session consisted of 2 sets of 10 x ~21.2m sprints with two 90o COD in each sprint and a resting period of 16 sec and 2:20 min between sprints and sets, respectively, iii) Control: Participants in this trial will only participate in daily assessments to control for day to day variability in the depended variables (they will not receive any intervention). Prior to each trial, participants will provide a resting blood sample (for the determination of blood lactate, white blood cell count and creatine kinase activity) and undergo assessment of their delayed onset of muscle soreness (DOMS), maximal voluntary isometric contraction (MVIC), countermovement jump [will be assessed using two force platforms at 1000 Hz and electromyography instrumentation (EMG)], isokinetic peak torque of knee extensors and flexors (will be assessed on an isokinetic dynamometer), agility (will be assessed using the Illinois test), 10m and 30m sprint time (will be assessed by using light cells) and repeated sprint ability (5x30m sprints will be performed with 25 sec rest in-between). In COD45 and COD90 experimental trials, a blood sample will be collected immediately post-training for the determination of blood lactate concentration while assessment of DOMS, MVIC and countermovement jump will be performed at 1, 2 and 3 hours post-training. In all trials assessment of DOMS, MVIC, countermovement jump (CMJ), isokinetic peak torque, agility and sprinting performance as well as determination of creatine kinase activity and white blood cell count will be performed at 24, 48 and 72 hours post-training. A 7-day wash out period will applied between trials.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date June 30, 2023
Est. primary completion date September 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Soccer players participating in at least 5 training sessions per week and 1official match - Participation at a competitive level for at least 4 years - Free of musculoskeletal injuries - No use of ergogenic supplements or medication - Non-smokers Exclusion Criteria: - Musculoskeletal injury - Use of alcohol, caffeine and any type of ergogenic supplements or medication during the course of the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
COD45
Participants will perform 2 sets of 10 sprints. The total distance for each sprint will be 27.6 meters and will include two changes of direction of 45 degrees. The recovery time will be 16 seconds between sprints and 2.20 minutes between sets
COD90
Participants will perform 2 sets of 10 sprints. The total distance for each sprint will be 21.2 meters and will include two changes of direction of 90 degrees. The recovery time will be 16 seconds between sprints and 2.20 minutes between sets

Locations

Country Name City State
Greece SMART LAB, Department of Physical Education and Sports Science, University of Thessaly. Trikala
Greece SmArT LABORATORY, SCHOOL OF PHYSICAL EDUCATION & SPORTS SCIENCES, UNIVERSITY OF THESSALY Trikala

Sponsors (1)

Lead Sponsor Collaborator
University of Thessaly

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in creatine kinase activity Creatine kinase activity will be measured in plasma At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in white blood cell count White blood cell count will be measured by using an automatic blood analyzer At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in delayed onset of muscle soreness Muscle soreness will be assessed by palpation of the muscle belly and the distal region At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in isometric peak torque Isometric peak torque will be assessed on an isokinetic dynamometer At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in fatigue index of maximal voluntary isometric contraction during 10 seconds Fatigue rate will be determined by calculating the percent drop of peak torque between the first and the last three seconds of a 10-second maximal isometric contraction At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in isokinetic peak torque of knee extensors Isokinetic peak torque will be assessed on an isokinetic dynamometer in both limbs At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in isokinetic peak torque of knee flexors Isokinetic peak torque will be assessed on an isokinetic dynamometer in both limbs At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in countermovement jump height Countermovement jump height will be assessed by using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height for each leg At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in ground reaction force during countermovement jump Ground reaction force will be assessed by using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height for each leg At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in peak power during countermovement jump Peak power will be assessed using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height for each leg At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in mean power during countermovement jump Mean power will be assessed using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height for each leg At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in vertical stiffness during countermovement jump Vertical stiffness will be assessed using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height for each leg At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in peak rate of force development during countermovement jump Peak rate of force development will be assessed using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height for each leg At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in peak normalized electromyography (EMG) during the eccentric and concentric phases of the countermovement jump EMG data will be collected wirelessly at 2000 Hz using a Myon MA-320 EMG system (Myon AG, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius and gluteus maximus muscles. At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in mean normalized electromyography (EMG) during the eccentric and concentric phases of the countermovement jump EMG data will be collected wirelessly at 2000 Hz using a Myon MA-320 EMG system (Myon AG, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius and gluteus maximus muscles. At baseline, at 1, 2, 3, 24, 48 and 72 hours after change of direction training session
Primary Change in repeated sprint ability Repeated sprint ability will be tested using 5x30 m sprints with 25 seconds rest in-between At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in sprint time of 10m 10m sprint time will be assessed using light cells At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in sprint time of 30m 30m sprint time will be assessed using light cells At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in agility Agility will be assessed using the illinois agility test. At baseline, at 24, 48 and 72 hours after change of direction training session
Primary Change in field activity during the change of direction training session Field activity will be continuously monitored during the change of direction training session by using global positioning system (GPS) During the change of direction training session
Primary Change in heart rate during the change of direction training session Heart rate will be continuously monitored during the change of direction training session by using heart rate monitors. During the change of direction training session
Primary Change in blood lactate concentration Blood lactate will be measured using a lactate plus system At baseline and immediately post change of direction training session
Secondary Body mass Body mass will me measured on a beam balance with stadiometer At baseline
Secondary Body height Body height will me measured on a beam balance with stadiometer At baseline
Secondary Body fat Body fat will be assessed by using Dual-emission X-ray absorptiometry At baseline
Secondary Lean body mass Lean body mass will be assessed by using Dual-emission X-ray absorptiometry At baseline
Secondary Maximal oxygen consumption (VO2max) VO2max will be measured by open circuit spirometry via breath by breath method At baseline
Secondary Yo-Yo Intermittent Endurance Test level 2 performance At baseline
Secondary Yo-Yo Intermittent Recovery Test level 2 performance At baseline
Secondary Dietary intake Dietary intake will be assessed over a 7-day period by using diet recalls At baseline
See also
  Status Clinical Trial Phase
Completed NCT03753321 - Whey and Soy Protein Supplementation in Football Players N/A
Completed NCT02816411 - Protein Supplementation and Skeletal Muscle Healing Process N/A
Completed NCT03348267 - Protein Supplementation and Muscle Recovery in Football N/A
Completed NCT02930031 - Redox Status and Immune Function N/A
Completed NCT01778309 - NAC Supplementation and Skeletal Muscle Performance N/A
Recruiting NCT06260215 - Recovery Kinetics Following a Soccer Training in Middle-aged Males N/A
Completed NCT03934762 - Aloe Vera Ointment Application and Skeletal Muscle Recovery N/A
Completed NCT04523675 - NAC Supplementation and Soccer Specific Performance N/A